Blue Horizon Enterprise Ltd sold $27.2M of Stoke Therapeutics (STOK)

Executed Sep 19 2024, disclosed Sep 23 2024, 4 days later.

Value, as filed

$27.2M

1,937,500 sh × $14.05

Executed

Sep 19 2024

the trade date, as filed

Disclosed

Sep 23 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BL Blue Horizon Enterprise Ltd 10% owner profile →

Blue Horizon Enterprise Ltd (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $23.0M of STOK (2,000,000 sh × $11.50, as filed), executed Dec 23 2024.

The name

STOK

Stoke Therapeutics, Inc. STOK · Healthcare · 35 filings in 24 months ticker →

Healthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Blue Horizon Enterprise Ltd in STOK

STOKSALE Stoke Therapeutics, Inc. $23.0M
2,000,000 sh × $11.50
Exec Dec 23 2024
Filed Dec 27 2024 · 5:30 PM ET †